Martínez-Pons V, Madrid V, Company R, Belda F J, Pérez Moya H, Ibáñez M T, Ortiz R
Servicio de Anestesiología, Hospital Francesc de Borja, Gandía, Paseo de Germanías, 71, 46700 Gandía, Valencia.
Rev Esp Anestesiol Reanim. 2001 Feb;48(2):53-8.
To study the usefulness of the NasOral system for denitrogenation prior to anesthetic induction for improving pulmonary oxygen storage that maintains SpO2 within the normal range during induced apnea and facilitates apneic oxygenation.
To establish the study population of 125, five hospitals of the Valencian Community (Spain) enrolled patients scheduled for elective procedures under general anesthesia. The patients were preoxygenated using the NasOral system (denitrogenation). For two minutes, the patients inhaled oxygen through the nose (FiO2 1) at a flow rate of 8-10 l/min (never less than the patient's own minute volume) and exhaled orally through a unidirectional valve. We measured time of apnea with SpO2 > or = 96% to assess the usefulness of the device for denitrogenation. We also measured PetCO2 after endotracheal intubation and after maximum time of apnea (< or = 10 minutes) to assess use of the device for apneic oxygenation during laryngoscopy.
We found no significant differences with regard to age, sex, ASA or Mallampati classification among patient groups enrolled at the participating hospitals. Cox's regression analysis was used to determine relative risk of SpO2 < 96%. At 10 minutes post-apnea, 88.8% of all patients maintained SpO2 > or = 96%. However, SpO2 > 96% was maintained by 94.1% in the Mallampati I group and by 84.1% in the Mallampati II group. SpO2 fell below the cut-off (< 96%) in 33.3% of obese patients and in 7.5% of non-obese patients. Analysis of the likelihood of SpO2 < 96% associated with the variables of obesity, sex, age, ASA and Mallampati classification was significant only for obesity, for which a risk of 1.95 was calculated relative to non-obesity (95% CI 1.14-3.35). The NasOral system allows performance of direct laryngoscopy for oral tracheal intubation, maintaining oxygen flow through the permeable airway to facilitate apneic oxygenation.
The NasOral system facilitates denitrogenation before induction of anesthesia in all patients with permeable nasal fossae as well as apneic oxygenation during laryngoscopy.
研究鼻口系统在麻醉诱导前脱氮以改善肺氧储备的作用,从而在诱导性呼吸暂停期间将脉搏血氧饱和度(SpO2)维持在正常范围内,并促进无呼吸氧合。
为建立125例的研究人群,西班牙巴伦西亚自治区的五家医院纳入了计划接受全身麻醉下择期手术的患者。患者使用鼻口系统进行预充氧(脱氮)。患者通过鼻子以8-10升/分钟的流速(绝不低于患者自身的分钟通气量)吸入氧气(FiO2 1)两分钟,同时通过单向阀经口呼气。我们测量了SpO2≥96%时的呼吸暂停时间,以评估该装置脱氮的有效性。我们还测量了气管插管后以及最长呼吸暂停时间(≤10分钟)后的呼气末二氧化碳分压(PetCO2),以评估该装置在喉镜检查期间用于无呼吸氧合的情况。
在参与研究的医院纳入的患者组中,我们发现年龄、性别、美国麻醉医师协会(ASA)分级或马兰帕蒂分级方面无显著差异。使用Cox回归分析来确定SpO2<96%的相对风险。呼吸暂停后10分钟,所有患者中有88.8%维持SpO2≥96%。然而,马兰帕蒂I组中94.1%的患者维持SpO2>96%,马兰帕蒂II组中这一比例为84.1%。33.3%的肥胖患者和7.5%的非肥胖患者的SpO2降至临界值以下(<96%)。对与肥胖、性别、年龄、ASA分级和马兰帕蒂分级等变量相关的SpO2<96%的可能性分析仅对肥胖有显著意义,相对于非肥胖患者,肥胖患者的风险计算为1.95(95%可信区间1.14-3.35)。鼻口系统允许进行直接喉镜检查以进行经口气管插管,维持通过可渗透气道的氧气流动以促进无呼吸氧合。
鼻口系统有助于所有鼻道通畅的患者在麻醉诱导前进行脱氮,并在喉镜检查期间实现无呼吸氧合。